Table 2 Characteristics of the patients.

From: Validation of three predictive models for suboptimal cytoreductive surgery in advanced ovarian cancer

 

Total N = 103

OCS N = 87

SCS N = 16

p value

Age

60 (51–67)

60 (51–67)

63 (55–67)

0.51

Current tumor

Primary

74 (71.8%)

63 (72.4%)

11 (68.8%)

0.76

Recurrent

29 (28.2%)

24 (27.6%)

5 (31.2%)

 

FIGO stage

III

79 (76.7%)

72 (82.8%)

7 (43.8%)

 < 0.001

IV

24 (23.3%)

15 (17.2%)

9 (56.2%)

 

Histology

Serous

71 (71%)

62 (72.9%)

9 (60%)

0.097

Adenocarcinoma

8 (8%)

4 (4.7%)

4 (26.7%)

 

Mucinous

2 (2%)

2 (2.4%)

0

 

Clear cells

3 (3%)

2 (2.4%)

1 (6.7%)

 

Endometroid

7 (7%)

6 (7.1%)

1 (6.7%)

 

Undifferentiated

5 (5%)

5 (5.9%)

0

 

Other

4 (4%)

4 (4.7%)

0

 

Charlson age index

 

2 (0–3)

2 (0–3)

2 (1–4)

0.40

Ascites in imaging tests

No

66 (64.1%)

59 (67.8%)

7 (43.8%)

0.06

Yes

37 (35.9%)

28 (32.2%)

9 (56.2%)

 

Intestinal occlusion in imaging tests

No

97 (94.2%)

83 (95.4%)

14 (87.5%)

0.21

Yes

6 (5.8%)

4 (4.6%)

2 (12.5%)

 

Preoperative malnutrition

No

78 (75.7%)

67 (70%)

11 (68.8%)

0.48

Yes

25 (24.3%)

20 (23%)

5 (31.2%)

 

Total CT scan PCI

 

12 (5–18)

11 (4–15)

17 (11–25)

0.004

Categorized CT scan PCI

1–10

50 (51%)

46 (55%)

4 (25%)

0.02

11–20

36 (36%)

29 (35%)

7 (44%)

 

20

13 (13%)

8 (10%)

5 (31%)

 

Total operative PCI

 

14 (7–20)

12 (5–15)

26 (21–33)

 < 0.001

Categorized operative PCI

1–10

41 (40.6%)

40 (47.1%)

1 (6.2%)

 < 0.001

11–20

35 (34.7%)

32 (37.6%)

3 (18.8%)

 

20

25 (24.8%)

13 (15.3%)

12 (75%)

 
  1. *Data are presented as n (%) and median (interquartile range).